Table III.
Summary of clinical and laboratory features of patients with probable SARSa
Virology for SARS-associated coronavirus |
||||||||
---|---|---|---|---|---|---|---|---|
Case no. | Sex | Age (years) | Close SARS contact | Lowest lymphocyte count (×109/L) in PB) (normal range for age) | Highest plasma lactate dehydrogenase (IU/L)b | RT-PCR | Viral isolation | Seroconversion |
1 | F | 0.33 | Yes | 2.0 (4.0–13.5) | 606 | Pos | Neg | Pos |
2 | M | 2 | Yes | 1.1 (3.0–9.5) | 308 | – | Pos | Pos |
3 | F | 5 | Yes | 1.1 (1.5–6.8) | 324 | – | Pos | Pos |
4 | F | 6 | Yes | 1.1 (1.5–6.8) | 275 | – | Neg | Neg |
5 | M | 7 | Yes | 1.2 (1.5–6.8) | 354 | – | Neg | Pos |
6 | M | 13 | Yes | 0.6 (1.2–5.2) | 413 | Neg | Neg | Pos |
7 | F | 14 | No | 0.4 (1.2–5.2) | 336 | Pos | Neg | Pos |
8 | M | 16 | Yes | 0.6 (1.2–5.2) | 224 | Pos | Neg | Pos |
9 | M | 17 | Yes | 0.5 (1.2–5.2) | 339 | Neg | Neg | Pos |
PB, peripheral blood; RT-PCR, reverse transcriptase-polymerase chain reaction; F, female; M, male; Neg, negative; Pos, positive.
All patients had chest radiographic abnormalities compatible with SARS.
Upper limit of normal was 213IU/L.